Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 789-798

  Wang, Lei ^a,b   Zhang, Haijun ^a,b   Chen, Baoan ^a,b   Xia, Guohua ^a,b   Wang, Shuai ^a,b   Cheng, Jian ^a,b   Shao, Zeye ^a,b   Gao, Chong ^a,b   Bao, Wen ^a,b   Tian, Liang ^a,b   Ren, Yanyan ^a,b   Xu, Peipei ^a,b   Cai, Xiaohui ^a,b   Liu, Ran ^a,b   Wang, Xuemei ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Medical School   (China)

Author keywords

Apoptosis; Caspase 3; Caspase 8; Cell cycle; Cyclin E; Magnetic nanoparticles; Raji cell; Survivin; Wogonin

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CASPASE 8; CYCLIN E; MAGNETIC NANOPARTICLE; METHYLTHIAZOL TETRAZOLIUM; SURVIVIN; TETRAZOLIUM; UNCLASSIFIED DRUG; WOGONIN; BIRC5 PROTEIN, HUMAN; FLAVANONE DERIVATIVE; HERBACEOUS AGENT; INHIBITOR OF APOPTOSIS PROTEIN; MAGNETITE NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STRUCTURE; FLOW CYTOMETRY; NANOFABRICATION; POLYMERIZATION; PROTEIN EXPRESSION; RAJI CELL; UPREGULATION; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CASPASE 8; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN E; DRUGS, CHINESE HERBAL; FLAVANONES; FLOW CYTOMETRY; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MAGNETITE NANOPARTICLES;

EID: 84862315293     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28089     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. van Besien K. Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. Curr Opin Oncol. 2011;23(6):681-691.
3. Dong P, Zhang Y, Gu J, et al. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. J Ethnopharmacol. 2011;137(3):1373-1380.
4. Chow SE, Chang YL, Chuang SF, Wang JS. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3iiand aNp63. Cancer Chemother Pharmacol. 2011;68(4):835-845.
5. Gao J, Morgan WA, Sanchez-Medina A, Corcoran O. The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. Toxicol Appl Pharmacol. 2011;254(3):221-228.
6. Yu J, Liu H, Lei J, Tan W, Hu X, Zou G. Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 2007;21(9):817-822.
7. Lee DH, Kim C, Zhang K, Lee YJ. Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol. 2008;75(10):2020-2033.
8. Xu H, Cheng L, Wang C, Ma X, Li Y, Liu Z. Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials. 2011;32(35):9364-9373.
9. 4nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cells. Int J Nanomedicine. 2011;6:1921-1927.
10. 4nanoparticles. Int J Nanomedicine. 2011;6:1929-1935.
11. von Maltzahn G, Park JH, Lin KY, et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater. 2011;10(7):545-552.
12. Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release. 2010;142(1):108-121.
13. Foy SP, Labhasetwar V. Oh the irony: iron as a cancer cause or cure? Biomaterials. 2011;32(35):9155-9158.
14. Guevara AP, Vargas C, Sakurai H, et al. An antitumor promoter from Moringa oleifera Lam. Mutat Res. 1999;440(2):181-188.
15. 4nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells. Int J Nanomedicine. 2009;4:107-114.
16. DeVita VT. Dose-response is alive and well. J Clin Oncol. 1986;4(8): 1157-1159.
17. Min LW. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev. 2009;35(1):57-68.
18. Ashley CE, Carnes EC, Phillips GK, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater. 2011;10(5):389-397.
19. Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011;29(7):323-332.
20. Jang JT, Nah H, Lee JH, Moon SH, Kim MG, Cheon J. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew Chem Int Ed Engl. 2009;48(7):1234-1238.
21. Comes Franchini M, Baldi G, Bonacchi D, et al. Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer. Small. 2010;6(3):366-370.
22. Goodarzi A, Sahoo Y, Swihart MT, Prasad PN. Aqueous ferrofluid of citric acid coated magnetite particles. Mater Res Soc Symp Proc. 2004;789:661-666.
23. 4nanoparticles: conjugation and release of doxorubicin for therapeutic applications. J Magn Magn Mater. 2011;323(2):237-243.
24. Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience. 2004;3(1):66-73.
25. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23(7):1553-1561.
26. Kerr JF, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer. 1994;73(8):2013-2026.
27. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
28. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999;6(11):1028-1042.
29. 4with gambogic acid on apoptosis of K562 leukemia cells. Int J Nanomedicine. 2009;4:251-259.
30. Fas SC, Baumann S, Zhu JY, et al. Wogonin sensitizes resistant malignant cells to TNFalpha-and TRAIL-induced apoptosis. Blood. 2006;108(12):3700-3706.
31. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res. 2008;14(16):5000-5005.